Pluristem Therapeutics To Present At Barclays And Regenmed Financial Conferences
HAIFA, Israel, March 11, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced that Company executives will present at two upcoming financial conferences:
Help employers find you! Check out all the jobs and post your resume.